News

All Press Release In The News

Sep 25,2026 Endpoint News

K2 Therapeutics Named as One of Biopharma’s Most Promising Startups of 2026 to the Endpoints 11
Aug 11,2026 Endpoint News

Ying Huang’s post-Legend life takes shape at K2, with $250M goal to license Asia assets
Apr 29,2026 Endpoints News

MPM has collected three China drugs so far for its ‘best of both worlds’ strategy